Chengdu Kangnuoxing Biopharma,inc.

This study aims to check the safety of a new injection called Stapokibart for adults with chronic sinusitis and nasal polyps (CRSwNP). Doctors will give the injection to 600 participants and carefully track any side effects that occur. The main goal is to see how safe the treatme…

This study aims to check the safety of a drug called Stapokibart Injection in people with SAR. It will enroll 400 adult participants who are already scheduled to receive this treatment. The main goal is to track and count any side effects or adverse reactions that occur.

This study is testing whether an injectable drug called stapokibart can help control moderate to severe bullous pemphigoid, a condition that causes painful, itchy skin blisters. Researchers will compare stapokibart against a placebo (inactive injection) in 200 adults to see if it…